Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
G6PD 5alpha-Androstan-17-one NA 200000 NA NA NA NA TTD
G6PD (3S,5S,8R,9S,10S,13S,14S)-3-amino-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one NA 200000 NA NA NA NA TTD
G6PD 3beta-Hydroxy-16alpha,17alpha-epoxy-5alpha-pregnan-20-one NA 200000 NA NA NA NA TTD
G6PD (2S,3S,4S,5R,6S)-2-(2-aminoethylsulfanylmethyl)-6-methoxyoxane-3,4,5-triol 2000000 NA NA NA NA NA TTD
G6PD 3-[[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methylsulfonyl]propanenitrile 200000 NA NA NA NA NA TTD
G6PD (2S,3S,4S,5R,6S)-2-(3-aminopropylsulfanylmethyl)-6-methoxyoxane-3,4,5-triol 129000 NA NA NA NA NA TTD
G6PD 2-amino-N-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl]ethanesulfonamide 400000 NA NA NA NA NA TTD
G6PD 3-[[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methylsulfanyl]propanenitrile 200000 NA NA NA NA NA TTD
G6PD 2-[2-[[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methylsulfanyl]ethyl]guanidine 200000 NA NA NA NA NA TTD
G6PD N-[(3S,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]acetamide NA 128000 NA NA NA NA TTD
G6PD (3S,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylspiro[1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-17,2'-oxirane]-3-ol NA 200000 NA NA NA NA TTD
G6PD Bnn-20 NA 200000 NA NA NA NA TTD
G6PD 1-[(3S,5S,8S,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-2-one NA 200000 NA NA NA NA TTD
G6PD (3S,5S,8R,9S,10S,13S,14S,17R)-10,13-dimethylspiro[1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-17,2'-oxetane]-3-ol NA 200000 NA NA NA NA TTD
G6PD 1-[(3S,5S,8R,9S,10S,13S,14S,17R)-3-hydroxy-17-methoxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone NA 200000 NA NA NA NA TTD
G6PD 3-[(3S,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]-1,1-dimethylurea NA 200000 NA NA NA NA TTD
G6PD (3beta,5alpha)-3-Aminopregnan-20-one NA 200000 NA NA NA NA TTD
G6PD N-[(3S,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetamide NA 200000 NA NA NA NA TTD
G6PD 3-[(3S,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1,1-dimethylurea NA 200000 NA NA NA NA TTD
G6PD methyl N-[(3S,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]carbamate NA 200000 NA NA NA NA TTD